An experimental drug, sourced from China, is under FDA scrutiny after marketing claims of being 'the ultimate good' and subsequent warnings were issued.
3 reports, 3 independent
Updated Aug 1
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
An experimental drug, sourced from China, is under FDA scrutiny after marketing claims of being 'the ultimate good' and subsequent warnings were issued.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Eli Lilly faces competitive pressure from Chinese labs, linked to Cambridge research.1 source
FDA issued warnings regarding the marketing and sales of a drug sourced from China.1 source
Keep exploring
The entities involved
-
Eli Lilly and Company
American pharmaceutical company
- FDA
-
China
cultural region, ancient civilization, and nation in East Asia; mostly refers to the People's Republic of China in political situation and rarely refers to the Republic of China
Related events
- Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.
- A product was launched in the U.S. market following FDA involvement.
- Eli Lilly's drug is being tested for market approval while also being advertised for illicit sales on TikTok in Brighton.
- Amylyx Pharmaceuticals is seeking FDA approval for a new drug treatment.
- FDA and Pfizer are seeking regulatory approval for their products.